Literature DB >> 12366895

Recruiting for a randomized controlled trial from an ethnically diverse population: lessons from the Maternal Infection and Preterm Labor Study.

Jennifer L Welsh1, Patricia Adam, Patricia Fontaine, Dwenda Gjerdingen.   

Abstract

OBJECTIVES: To compare recruitment rates for Caucasians and minorities in a randomized, controlled trial based in a family practice residency clinic. STUDY
DESIGN: A retrospective chart review of all patients eligible for the Maternal Infection and Preterm Labor (MIPTL) study. POPULATION: All prenatal patients at 1 clinic site presenting for care at earlier than 34 weeks gestation.
RESULTS: African-American patients were recruited at the same rate as Caucasians (28% of each eligible population). Immigrants and patients requiring a translator were less likely to enroll (P =.014 and.008, respectively).
CONCLUSIONS: Clinic-based research studies in a family practice residency program can successfully recruit African-American patients. Immigration status and the ability to speak English were important factors impacting participation. More research is needed to understand the role of clinic-based research in recruitment of minorities for clinical trials.

Entities:  

Mesh:

Year:  2002        PMID: 12366895

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  2 in total

1.  Factors influencing enrollment of African Americans in the Look AHEAD trial.

Authors:  David L Mount; Cralen Davis; Betty Kennedy; Susan Raatz; Kathy Dotson; Tiffany L Gary-Webb; Sheikilya Thomas; Karen C Johnson; Mark A Espeland
Journal:  Clin Trials       Date:  2011-11-07       Impact factor: 2.486

2.  Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].

Authors:  Kate Jolly; Gregory Y Lip; Rod S Taylor; Jonathan W Mant; Deirdre A Lane; Kaeng W Lee; Andrew J Stevens
Journal:  BMC Med Res Methodol       Date:  2005-05-17       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.